300896 爱美客
已收盘 04-30 15:00:00
资讯
新帖
简况
爱美客:公司研发项目进度会按照相关法规要求在定期报告中披露
证券之星 · 04-30
爱美客:公司研发项目进度会按照相关法规要求在定期报告中披露
太平洋:给予爱美客买入评级
证券之星 · 04-29
太平洋:给予爱美客买入评级
上海证券:给予爱美客买入评级
证券之星 · 04-29
上海证券:给予爱美客买入评级
山西证券:给予爱美客买入评级
证券之星 · 04-28
山西证券:给予爱美客买入评级
财信证券:给予爱美客买入评级,目标价位349.5元
证券之星 · 04-28
财信证券:给予爱美客买入评级,目标价位349.5元
东方财富证券:给予爱美客增持评级
证券之星 · 04-26
东方财富证券:给予爱美客增持评级
中邮证券:给予爱美客买入评级
证券之星 · 04-26
中邮证券:给予爱美客买入评级
【机构调研记录】易米基金调研爱美客
证券之星 · 04-26
【机构调研记录】易米基金调研爱美客
【机构调研记录】新沃基金调研爱美客
证券之星 · 04-26
【机构调研记录】新沃基金调研爱美客
【机构调研记录】国海富兰克林基金调研电连技术、爱美客
证券之星 · 04-26
【机构调研记录】国海富兰克林基金调研电连技术、爱美客
【机构调研记录】南华基金调研当升科技、爱美客
证券之星 · 04-26
【机构调研记录】南华基金调研当升科技、爱美客
爱美客(300896)2024年一季报简析:营收净利润同比双双增长
证券之星 · 04-26
爱美客(300896)2024年一季报简析:营收净利润同比双双增长
万联证券:给予爱美客买入评级
证券之星 · 04-25
万联证券:给予爱美客买入评级
民生证券:给予爱美客买入评级
证券之星 · 04-25
民生证券:给予爱美客买入评级
爱美客获信达证券买入评级,归母/扣非归母净利润偏预告上缘,期待核心管线保持优异增长&新管线逐步放量
金融界 · 04-25
爱美客获信达证券买入评级,归母/扣非归母净利润偏预告上缘,期待核心管线保持优异增长&新管线逐步放量
信达证券:给予爱美客买入评级
证券之星 · 04-25
信达证券:给予爱美客买入评级
一季报验证业绩强劲增长 爱美客(300896.SZ)何以强者恒强?
智通财经 · 04-25
一季报验证业绩强劲增长 爱美客(300896.SZ)何以强者恒强?
开源证券:给予爱美客买入评级
证券之星 · 04-25
开源证券:给予爱美客买入评级
中国银河:给予爱美客买入评级
证券之星 · 04-25
中国银河:给予爱美客买入评级
东吴证券:给予爱美客买入评级
证券之星 · 04-25
东吴证券:给予爱美客买入评级
加载更多
公司概况
公司名称:
爱美客技术发展股份有限公司
所属行业:
专用设备制造业
上市日期:
2020-09-28
主营业务:
爱美客技术发展股份有限公司成是一家从事生物医用材料及生物医药产品研发与转化的国家高新技术企业。公司目前的主要产品为:基于透明质酸钠的系列皮肤填充剂、基于聚左旋乳酸的皮肤填充剂、面部埋植线产品等。公司透明质酸钠类注射产品2018至2021年在国产厂商中市场份额排名蝉联第一。公司已拥有八款获得国家药监局批准的Ⅲ类医疗器械产品,是国内获得国家药监局认证用于非手术医疗美容Ⅲ类医疗器械数量最多的企业。
发行价格:
118.27
{"stockData":{"symbol":"300896","market":"SZ","secType":"STK","nameCN":"爱美客","latestPrice":214.8,"timestamp":1714460637000,"preClose":217.8,"halted":0,"volume":2830050,"delay":0,"floatShares":208000000,"shares":302000000,"eps":6.5199,"marketStatus":"已收盘","marketStatusCode":5,"change":-3,"latestTime":"04-30 15:00:00","open":218,"high":222,"low":214.61,"amount":614000000,"amplitude":0.0339,"askPrice":214.8,"askSize":17,"bidPrice":214.79,"bidSize":2,"shortable":0,"etf":0,"ttmEps":6.5199,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"adjPreClose":217.8,"symbolType":"stock","openAndCloseTimeList":[[1714440600000,1714447800000],[1714453200000,1714460400000]],"highLimit":239.58,"lowLimit":196.02,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":302437650,"pbRate":9.57,"roa":"--","roe":"7.97%","epsLYR":8.6,"committee":-0.456311,"marketValue":64964000000,"floatMarketCap":44778000000,"peRate":32.945291,"changeRate":-0.0138,"turnoverRate":0.0136,"status":1},"requestUrl":"/m/hq/s/300896/","defaultTab":"news","newsList":[{"id":"2431431296","title":"爱美客:公司研发项目进度会按照相关法规要求在定期报告中披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2431431296","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431431296?lang=zh_cn&edition=full","pubTime":"2024-04-30 19:03","pubTimestamp":1714474985,"startTime":"0","endTime":"0","summary":"证券之星消息,爱美客(300896)04月30日在投资者关系平台上答复投资者关心的问题。投资者:公司的新产品啥时候上市呢爱美客董秘:尊敬的投资者您好,公司研发项目进度会按照相关法规要求在定期报告中披露,请您关注公司公告,谢谢。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000045791.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431075771","title":"太平洋:给予爱美客买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2431075771","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431075771?lang=zh_cn&edition=full","pubTime":"2024-04-29 12:56","pubTimestamp":1714366615,"startTime":"0","endTime":"0","summary":"太平洋证券股份有限公司郭彬,龚书慧近期对爱美客进行研究并发布了研究报告《2024Q1财报点评:业绩符合预期,期待核心产品驱动增长》,本报告对爱美客给出买入评级,当前股价为219.88元。我们维持此前对公司的盈利预测,2024-26年归母净利润分别为24.5/31.8/39.9亿元,对应PE分别为26/20/16倍,给予“买入”评级。最新盈利预测明细如下:该股最近90天内共有41家机构给出评级,买入评级35家,增持评级6家;过去90天内机构目标均价为435.41。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900008781.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431025412","title":"上海证券:给予爱美客买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2431025412","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431025412?lang=zh_cn&edition=full","pubTime":"2024-04-29 10:52","pubTimestamp":1714359129,"startTime":"0","endTime":"0","summary":"上海证券有限责任公司梁瑞近期对爱美客进行研究并发布了研究报告《公司点评:24Q1归母净利润yoy+27.38%,业绩符合预期》,本报告对爱美客给出买入评级,当前股价为221.36元。 爱美客 投资摘要 事件概述 公司发布2024年第一季度报告。EPS分别为11.60/15.01/19.04,对应PE分别26/20/16倍,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有41家机构给出评级,买入评级35家,增持评级6家;过去90天内机构目标均价为435.41。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900007411.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430700823","title":"山西证券:给予爱美客买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430700823","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430700823?lang=zh_cn&edition=full","pubTime":"2024-04-28 12:46","pubTimestamp":1714279569,"startTime":"0","endTime":"0","summary":"山西证券股份有限公司王冯,张晓霖近期对爱美客进行研究并发布了研究报告《盈利水平稳定,费用改善明显》,本报告对爱美客给出买入评级,当前股价为297.01元。期内扣非归母净利润增速快于营收增速,公司品牌效应凸显。最新盈利预测明细如下:该股最近90天内共有41家机构给出评级,买入评级35家,增持评级6家;过去90天内机构目标均价为435.41。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800002259.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430704637","title":"财信证券:给予爱美客买入评级,目标价位349.5元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430704637","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430704637?lang=zh_cn&edition=full","pubTime":"2024-04-28 09:23","pubTimestamp":1714267392,"startTime":"0","endTime":"0","summary":"财信证券股份有限公司张曦月近期对爱美客进行研究并发布了研究报告《业绩增长符合预期,期待核心产品持续放量》,本报告对爱美客给出买入评级,认为其目标价位为349.50元,当前股价为297.01元,预期上涨幅度为17.67%。最新盈利预测明细如下:该股最近90天内共有41家机构给出评级,买入评级35家,增持评级6家;过去90天内机构目标均价为435.41。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800000881.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430522921","title":"东方财富证券:给予爱美客增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430522921","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430522921?lang=zh_cn&edition=full","pubTime":"2024-04-26 18:15","pubTimestamp":1714126529,"startTime":"0","endTime":"0","summary":"东方财富证券股份有限公司高博文,陈子怡近期对爱美客进行研究并发布了研究报告《2024年一季报点评:24Q1归母净利润同比+27%,关注医美龙头的中长期成长空间》,本报告对爱美客给出增持评级,当前股价为297.01元。我们维持预计24-26年公司归母净利润各25.6/33.6/43.2亿元,增速各37.5%/31.5%/28.5%;EPS各11.81/15.53/19.95元,对应PE分别为25/19/15倍,维持“增持”评级。最新盈利预测明细如下:该股最近90天内共有41家机构给出评级,买入评级35家,增持评级6家;过去90天内机构目标均价为435.41。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600044885.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430929893","title":"中邮证券:给予爱美客买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430929893","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430929893?lang=zh_cn&edition=full","pubTime":"2024-04-26 09:34","pubTimestamp":1714095286,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司李媛媛近期对爱美客进行研究并发布了研究报告《收入业绩增长符合预期,维持较高净利率》,本报告对爱美客给出买入评级,当前股价为293.3元。综合,公司24Q1归母净利率同比降低0.4pct至65.3%。最新盈利预测明细如下:该股最近90天内共有41家机构给出评级,买入评级35家,增持评级6家;过去90天内机构目标均价为435.41。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600021287.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430402261","title":"【机构调研记录】易米基金调研爱美客","url":"https://stock-news.laohu8.com/highlight/detail?id=2430402261","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430402261?lang=zh_cn&edition=full","pubTime":"2024-04-26 08:02","pubTimestamp":1714089772,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及4月25日披露的机构调研信息,易米基金近期对1家上市公司进行了调研,相关名单如下:1)爱美客 个股亮点:已成功实现注射类透明质酸钠及聚对二氧环己酮面部埋植线的产业化;公司产品包括应用于车载激光雷达的MEMS微振镜、车载显示领域的DDIC及TDDI等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600016033.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430261437","title":"【机构调研记录】新沃基金调研爱美客","url":"https://stock-news.laohu8.com/highlight/detail?id=2430261437","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430261437?lang=zh_cn&edition=full","pubTime":"2024-04-26 08:02","pubTimestamp":1714089768,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及4月25日披露的机构调研信息,新沃基金近期对1家上市公司进行了调研,相关名单如下:1)爱美客 个股亮点:已成功实现注射类透明质酸钠及聚对二氧环己酮面部埋植线的产业化;公司产品包括应用于车载激光雷达的MEMS微振镜、车载显示领域的DDIC及TDDI等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600016029.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430614742","title":"【机构调研记录】国海富兰克林基金调研电连技术、爱美客","url":"https://stock-news.laohu8.com/highlight/detail?id=2430614742","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430614742?lang=zh_cn&edition=full","pubTime":"2024-04-26 08:02","pubTimestamp":1714089735,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及4月25日披露的机构调研信息,国海富兰克林基金近期对2家上市公司进行了调研,相关名单如下:1)电连技术 个股亮点:公司对英伟达有公司相关产品的研发送样;公司表示小米公司是公司的重要客户。国海富兰克林基金成立于2004年,截至目前,资产管理规模711.08亿元,排名68/203;资产管理规模451.89亿元,排名75/203;管理公募基金数83只,排名73/203;旗下公募基金经理17人,排名76/203。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600016001.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430614162","title":"【机构调研记录】南华基金调研当升科技、爱美客","url":"https://stock-news.laohu8.com/highlight/detail?id=2430614162","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430614162?lang=zh_cn&edition=full","pubTime":"2024-04-26 08:01","pubTimestamp":1714089717,"startTime":"0","endTime":"0","summary":";公司利拉鲁肽注射液项目已完成I期临床试验。南华基金成立于2016年,截至目前,资产管理规模215.48亿元,排名113/203;资产管理规模215.48亿元,排名103/203;管理公募基金数29只,排名122/203;旗下公募基金经理6人,排名136/203。旗下最近一年表现最佳的公募基金产品为南华瑞诚一年定开债发起,最新单位净值为1.06,近一年增长4.87%。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600015988.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430826319","title":"爱美客(300896)2024年一季报简析:营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2430826319","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430826319?lang=zh_cn&edition=full","pubTime":"2024-04-26 06:28","pubTimestamp":1714084133,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期爱美客发布2024年一季报。根据财报显示,本报告期中爱美客营收净利润同比双双增长。截至本报告期末,公司营业总收入8.08亿元,同比上升28.24%,归母净利润5.27亿元,同比上升27.38%。营收分析方面,公司最新一期年度报表的现金流为正,经营性现金流和利润相匹配。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600013971.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430814283","title":"万联证券:给予爱美客买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430814283","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430814283?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:11","pubTimestamp":1714050664,"startTime":"0","endTime":"0","summary":"万联证券股份有限公司陈雯近期对爱美客进行研究并发布了研究报告《2024Q1业绩点评报告:业绩增速放缓,研发投入持续加强》,本报告对爱美客给出买入评级,当前股价为293.18元。目前估值已具备性价比,综合考虑公司自身实力以及行业发展趋势,维持公司“买入”投资评级。最新盈利预测明细如下:该股最近90天内共有41家机构给出评级,买入评级35家,增持评级6家;过去90天内机构目标均价为435.41。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500044486.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430020364","title":"民生证券:给予爱美客买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430020364","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430020364?lang=zh_cn&edition=full","pubTime":"2024-04-25 20:15","pubTimestamp":1714047348,"startTime":"0","endTime":"0","summary":"民生证券股份有限公司刘文正,郑紫舟,褚菁菁近期对爱美客进行研究并发布了研究报告《2024年一季报点评:24Q1归母净利润同比+27%,增长符合预期》,本报告对爱美客给出买入评级,当前股价为293.18元。 爱美客 事件概述:4月24日,爱美客发布2024年第一季度报告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500042616.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430401620","title":"爱美客获信达证券买入评级,归母/扣非归母净利润偏预告上缘,期待核心管线保持优异增长&新管线逐步放量","url":"https://stock-news.laohu8.com/highlight/detail?id=2430401620","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2430401620?lang=zh_cn&edition=full","pubTime":"2024-04-25 19:54","pubTimestamp":1714046065,"startTime":"0","endTime":"0","summary":"4月25日,爱美客获信达证券买入评级,近一个月爱美客获得12份研报关注。研报预计在核心管线保持优异增长、后续新品获批/放量有望提供新增长点的趋势下,2024-2026年归母净利润分别为24.51/31.76/40.58亿元,同比分别增长31.9%/29.6%/27.8%。研报认为,期待新品获批/逐步放量后继续提供收入增量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251954288b52ea33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate","earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251954288b52ea33&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430409175","title":"信达证券:给予爱美客买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430409175","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430409175?lang=zh_cn&edition=full","pubTime":"2024-04-25 19:31","pubTimestamp":1714044661,"startTime":"0","endTime":"0","summary":"信达证券股份有限公司刘嘉仁,周子莘,李汶静近期对爱美客进行研究并发布了研究报告《24Q1财报点评:归母/扣非归母净利润偏预告上缘,期待核心管线保持优异增长&新管线逐步放量》,本报告对爱美客给出买入评级,当前股价为293.18元。最新盈利预测明细如下:该股最近90天内共有41家机构给出评级,买入评级35家,增持评级6家;过去90天内机构目标均价为435.41。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500040851.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430471481","title":"一季报验证业绩强劲增长 爱美客(300896.SZ)何以强者恒强?","url":"https://stock-news.laohu8.com/highlight/detail?id=2430471481","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430471481?lang=zh_cn&edition=full","pubTime":"2024-04-25 17:45","pubTimestamp":1714038348,"startTime":"0","endTime":"0","summary":"日前,国内领先的医疗美容产品提供商爱美客披露了2024年第一季度业绩报告。同期,爱美客的凝胶类注射产品实现收入11.6亿元,占比40%,同比增长81%。如文首所述,今年一季度爱美客的收入同比增加了28.2%至8.08亿元,规模稳增的同时,公司的盈利表现也同样强悍。数据显示,Q1期间爱美客的归母净利润为5.27亿元,同比增加了27.4%;扣非归母净利润为5.28亿元,增幅更是高达36.5%。而若剔除这部分影响,爱美客的归母净利润增速料将也保持在三成以上。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1110009.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430069425","title":"开源证券:给予爱美客买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430069425","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430069425?lang=zh_cn&edition=full","pubTime":"2024-04-25 14:55","pubTimestamp":1714028136,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司黄泽鹏,杨柏炜近期对爱美客进行研究并发布了研究报告《公司信息更新报告:一季度经营业绩符合预期,看好医美龙头长期成长》,本报告对爱美客给出买入评级,当前股价为293.22元。最新盈利预测明细如下:该股最近90天内共有41家机构给出评级,买入评级35家,增持评级6家;过去90天内机构目标均价为435.41。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500025127.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430425066","title":"中国银河:给予爱美客买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430425066","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430425066?lang=zh_cn&edition=full","pubTime":"2024-04-25 14:50","pubTimestamp":1714027828,"startTime":"0","endTime":"0","summary":"中国银河证券股份有限公司程培,孟熙近期对爱美客进行研究并发布了研究报告《2024年一季报业绩点评:一季度业绩符合预期,看好核心产品放量》,本报告对爱美客给出买入评级,当前股价为293.02元。2024Q1公司研发费用0.58亿元,占营收比例为7.13%,持续通过自主研发与对外合作方式提升研发产出。最新盈利预测明细如下:该股最近90天内共有41家机构给出评级,买入评级35家,增持评级6家;过去90天内机构目标均价为435.41。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500025104.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430244244","title":"东吴证券:给予爱美客买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430244244","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430244244?lang=zh_cn&edition=full","pubTime":"2024-04-25 13:20","pubTimestamp":1714022438,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司朱国广,吴劲草,张家璇,孙瑜,冉胜男近期对爱美客进行研究并发布了研究报告《2024年一季报点评:业绩符合预期,归母/扣非归母净利润增速27%/37%》,本报告对爱美客给出买入评级,当前股价为293.27元。考虑到公司在医美领域的品牌和渠道优势,产品线逐步丰富,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有41家机构给出评级,买入评级35家,增持评级6家;过去90天内机构目标均价为435.41。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500024648.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-09-28","address":"北京市昌平区科技园区白浮泉路10号北控科技大厦4层416B室","stockEarnings":[{"period":"1week","weight":0.0476},{"period":"1month","weight":-0.1226},{"period":"3month","weight":0.1189},{"period":"6month","weight":-0.0442},{"period":"1year","weight":-0.4368},{"period":"ytd","weight":0.0297}],"companyName":"爱美客技术发展股份有限公司","boardCode":"AI0035","perCapita":"3865股","boardName":"专用设备制造业","registeredCapital":"30243万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":" 爱美客技术发展股份有限公司成是一家从事生物医用材料及生物医药产品研发与转化的国家高新技术企业。公司目前的主要产品为:基于透明质酸钠的系列皮肤填充剂、基于聚左旋乳酸的皮肤填充剂、面部埋植线产品等。公司透明质酸钠类注射产品2018至2021年在国产厂商中市场份额排名蝉联第一。公司已拥有八款获得国家药监局批准的Ⅲ类医疗器械产品,是国内获得国家药监局认证用于非手术医疗美容Ⅲ类医疗器械数量最多的企业。","serverTime":1714875175085,"listedPrice":118.27,"stockholders":"53928人(较上一季度增加1.19%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"爱美客(300896)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供爱美客(300896)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"爱美客,300896,爱美客股票,爱美客股票老虎,爱美客股票老虎国际,爱美客行情,爱美客股票行情,爱美客股价,爱美客股市,爱美客股票价格,爱美客股票交易,爱美客股票购买,爱美客股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"爱美客(300896)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供爱美客(300896)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}